» Authors » Andreia Miranda

Andreia Miranda

Explore the profile of Andreia Miranda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 41
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peixoto A, Ferreira D, Miranda A, Relvas-Santos M, Freitas R, Veth T, et al.
iScience . 2025 Feb; 28(2):111758. PMID: 39906564
Bladder tumors with aggressive characteristics often present microenvironmental niches marked by low oxygen levels (hypoxia) and limited glucose supply due to inadequate vascularization. The molecular mechanisms facilitating cellular adaptation to...
2.
Cotton S, Ferreira D, Relvas-Santos M, Brandao A, Afonso L, Miranda A, et al.
Mol Oncol . 2024 Nov; 19(3):635-658. PMID: 39508360
Colorectal cancer (CRC) cells express sialylated Lewis antigens (sLe), crucial for metastasis via E-selectin binding. However, these glycoepitopes lack cancer specificity, and E-selectin-targeted glycoproteins remain largely unknown. Here, we established...
3.
Freitas R, Ferreira E, Miranda A, Ferreira D, Relvas-Santos M, Castro F, et al.
ACS Nano . 2024 Mar; 18(14):10088-10103. PMID: 38535625
Advanced-stage solid primary tumors and metastases often express mucin 16 (MUC16), carrying immature glycans such as the Tn antigen, resulting in specific glycoproteoforms not found in healthy human tissues. This...
4.
Freitas R, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Ferreira E, et al.
J Control Release . 2024 Feb; 367:540-556. PMID: 38301927
Cancer presents a high mortality rate due to ineffective treatments and tumour relapse with progression. Cancer vaccines hold tremendous potential due to their capability to eradicate tumour and prevent relapse....
5.
Freitas R, Peixoto A, Ferreira E, Miranda A, Santos L, Ferreira J
Biotechnol Adv . 2023 Apr; 65:108144. PMID: 37028466
Cancer remains a leading cause of death worldwide due to the lack of safer and more effective therapies. Cancer vaccines developed from neoantigens are an emerging strategy to promote protective...
6.
Gaiteiro C, Soares J, Relvas-Santos M, Peixoto A, Ferreira D, Paulo P, et al.
Theranostics . 2022 May; 12(7):3150-3177. PMID: 35547758
Bladder cancer (BC) management demands the introduction of novel molecular targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential biomarker of BC aggressiveness and...
7.
Peixoto A, Miranda A, Santos L, Ferreira J
J Exp Clin Cancer Res . 2022 Apr; 41(1):143. PMID: 35428302
Cancer cells can evade immune responses by exploiting inhibitory immune checkpoints. Immune checkpoint inhibitor (ICI) therapies based on anti-CTLA-4 and anti-PD-1/PD-L1 antibodies have been extensively explored over the recent years...
8.
Neves M, Miranda A, Lemos M, Silva S, Tecelao C
J Food Sci . 2020 Aug; 85(9):2812-2821. PMID: 32820553
This study aimed to evaluate the effect of ethanolic extract of Pterospartum tridentatum flowers in the stability of sunflower oil. The extract was characterized regarding to its antioxidant activity by...
9.
Steluti J, Carvalho A, Carioca A, Miranda A, Gattas G, Fisberg R, et al.
Nutrients . 2017 Jun; 9(6). PMID: 28587068
Folate and other B vitamins are essential co-factors of one-carbon metabolism, and genetic variants, such as polymorphisms, can alter the metabolism. Furthermore, the adoption of food fortification with folic acid...
10.
Silva A, Miranda A, Fernandes E, Santos S, Fraga I, Santos D, et al.
Appl Biochem Biotechnol . 2013 Jan; 169(6):1919-26. PMID: 23354498
Fungi have been used for medicinal purposes for long time by Asian countries, being a putative source of powerful new phytopharmaceuticals such as polysaccharides. The aim of this study was...